NO994309D0 - FremgangsmÕter for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner - Google Patents

FremgangsmÕter for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner

Info

Publication number
NO994309D0
NO994309D0 NO994309A NO994309A NO994309D0 NO 994309 D0 NO994309 D0 NO 994309D0 NO 994309 A NO994309 A NO 994309A NO 994309 A NO994309 A NO 994309A NO 994309 D0 NO994309 D0 NO 994309D0
Authority
NO
Norway
Prior art keywords
isoprenoids
statins
combinations
methods
tumor growth
Prior art date
Application number
NO994309A
Other languages
English (en)
Other versions
NO994309L (no
Inventor
Charles Elson
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of NO994309L publication Critical patent/NO994309L/no
Publication of NO994309D0 publication Critical patent/NO994309D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO994309A 1997-03-04 1999-09-03 FremgangsmÕter for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner NO994309D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3979097P 1997-03-04 1997-03-04
PCT/US1998/003470 WO1998038993A1 (en) 1997-03-04 1998-02-23 Method of suppressing tumor growth with combinations of isoprenoids and statins

Publications (2)

Publication Number Publication Date
NO994309L NO994309L (no) 1999-09-03
NO994309D0 true NO994309D0 (no) 1999-09-03

Family

ID=21907353

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994309A NO994309D0 (no) 1997-03-04 1999-09-03 FremgangsmÕter for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner

Country Status (13)

Country Link
US (2) US6133312A (no)
EP (1) EP0986383A1 (no)
JP (1) JP2001507363A (no)
KR (1) KR20000075919A (no)
AU (1) AU729355B2 (no)
BR (1) BR9808157A (no)
CA (1) CA2283333A1 (no)
HU (1) HUP0002049A2 (no)
IL (1) IL131628A0 (no)
NO (1) NO994309D0 (no)
PL (1) PL335506A1 (no)
RU (1) RU2179440C2 (no)
WO (1) WO1998038993A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6251400B1 (en) * 1997-09-26 2001-06-26 Kgk Synergize Inc Compositions and methods of treatment of neoplastic diseases and hypercholesterolemia with citrus limonoids and flavonoids and tocotrienols
US6239114B1 (en) * 1997-09-26 2001-05-29 Kgk Synergize Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols
US6703384B2 (en) * 1998-09-23 2004-03-09 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
ATE307601T1 (de) * 1998-12-07 2005-11-15 Ecosmart Technologies Inc Brustkrebsbehandlung mittels natürlicher ätherischer öle
KR100847678B1 (ko) * 2000-02-11 2008-07-23 리서치 디벨럽먼트 파운데이션 토코페롤, 토코트리에놀, 다른 크로만 및 측쇄 유도체, 및이들의 용도
US20030104090A1 (en) * 2000-05-05 2003-06-05 Levy Pedro E. Supplements containing annatto extracts and carotenoids and methods for using the same
US6566397B2 (en) 2000-07-18 2003-05-20 Wisconsin Alumni Research Foundation Acyclic isoprenoid ether derivatives as chemotherapeutics
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
US7074825B2 (en) * 2002-03-07 2006-07-11 Huanbiao Mo Composition and method for treating cancer
US7989006B2 (en) * 2003-04-08 2011-08-02 American River Nutrition, Inc. Annatto extract compositions, including geranyl geraniols and methods of use
EP2465516A1 (en) * 2003-04-08 2012-06-20 Barrie Tan Annatto extract compositions, including geranyl geraniols and methods of use
US20050037102A1 (en) * 2003-07-18 2005-02-17 Barrie Tan Annatto extract compositions including tocotrienols and tocopherols and methods of use
WO2005094814A1 (ja) * 2004-03-31 2005-10-13 Kowa Co., Ltd. 外用剤
KR20070088325A (ko) * 2004-05-26 2007-08-29 케이지케이 시너자이즈 인코포레이티드 플라보노이드 및 토코트리에놀을 포함하는 조성물 및그에따른 방법
DE102006008074B4 (de) * 2006-02-22 2013-08-14 RUHR-UNIVERSITäT BOCHUM Behandlung von Krebs mit Geruchsrezeptor-Liganden
US8288369B2 (en) * 2006-06-27 2012-10-16 University Of South Florida Delta-tocotrienol treatment and prevention of pancreatic cancer
US20090004290A1 (en) * 2007-06-30 2009-01-01 Voelker Kirk G Red yeast rice compound for cancer chemoprevention
US8268786B2 (en) * 2009-04-23 2012-09-18 First Tech International Limited Anti-cancer tocotrienol analogues and associated methods
US9180113B2 (en) * 2009-09-01 2015-11-10 First Tech International Limited Tocotrienol compositions
US8969303B2 (en) * 2010-02-05 2015-03-03 First Tech International Limited Tocotrienol esters
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose
EP3043807B1 (en) 2013-09-13 2023-11-01 BioVentures, LLC Preparation and use of a composition for prevention and mitigation of the effects of radiation
US20160324914A1 (en) 2015-05-05 2016-11-10 Tocol Pharmaceuticals, Llc Use of rice bran oil distillate extract for prevention and mitigation of the effects of radiation

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33885A (en) * 1861-12-10 Improvement
US34617A (en) * 1862-03-04 Improved cylinder for grain scouring and thrashing machines
USRE33885E (en) 1975-11-03 1992-04-14 The Procter & Gamble Company Compositions for inhibiting absorption of cholesterol
US4005196A (en) 1976-02-12 1977-01-25 The Procter & Gamble Company Vitaminized compositions for treating hypercholesterolemia
US4789554A (en) * 1985-12-05 1988-12-06 The Procter & Gamble Company High temperature vacuum steam distillation process to purify and increase the frylife of edible oils
AU618791B2 (en) * 1988-03-16 1992-01-09 Bioindustry Development Centre Production of high concentration tocopherols and tocotrienols from palm oil by-product
DE3903991A1 (de) * 1989-02-10 1990-08-30 Basf Ag Phenylhydrazone des (beta)-jonons, ihre herstellung und daraus hergestellte arzneimittel und kosmetika
US5217992A (en) * 1989-10-04 1993-06-08 Bristol-Myers Squibb Company Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
US5554647A (en) * 1989-10-12 1996-09-10 Perricone; Nicholas V. Method and compositions for treatment and/or prevention of skin damage and aging
US5574063A (en) * 1989-10-12 1996-11-12 Perricone; Nicholas V. Method and compositions for topical application of ascorbic acid fatty acid esters for treatment and/or prevention of skin damage
US5157132A (en) * 1990-05-18 1992-10-20 Carotech Associates Integrated process for recovery of carotenoids and tocotrienols from oil
US5393776A (en) * 1990-09-14 1995-02-28 Bristol-Myers Squibb Company Tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
US5204373A (en) * 1991-08-26 1993-04-20 Bristol-Myers Squibb Company Farnesylated tetrahydro-naphthalenols as hypolipidemic agents
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
EP0543417A1 (en) * 1991-11-22 1993-05-26 Lipogenics, Incorporated Tocotrienols and tocotrienol-like compounds and methods for their use
AU4275793A (en) * 1992-02-25 1993-09-13 Warner-Lambert Company Cytoprotective compositions containing pyruvate and antioxidants
IL104736A0 (en) * 1992-03-27 1993-06-10 Zeagen Inc Method for producing beta-carotene using a fungal mated culture
JPH08503451A (ja) * 1992-05-13 1996-04-16 アメリカ合衆国 癌治療のモダリティーとしての３‐ヒドロキシ‐３‐メチルグルタリルＣｏＡレダクターゼ阻害剤の使用
US5376361A (en) * 1993-01-13 1994-12-27 Perricone; Nicholas V. Method and compositions for topical application to the skin for prevention and/or treatment of radiation-induced skin damage
US5411969A (en) * 1993-04-16 1995-05-02 Bristol-Myers Squibb Company Antihyperlipidemic/antioxidant dihydroquinolines
US5391765A (en) * 1993-04-16 1995-02-21 Bristol-Myers Squibb Company Cholesterol lowering/antioxidant nitroxides
US5475029A (en) * 1993-07-08 1995-12-12 The Board Of Trustees Of The Leland Stanford Junior University Farnesyl compounds as cholesterol lowering agents
US5500154A (en) * 1994-10-20 1996-03-19 The Procter & Gamble Company Detergent compositions containing enduring perfume

Also Published As

Publication number Publication date
AU729355B2 (en) 2001-02-01
US6133312A (en) 2000-10-17
CA2283333A1 (en) 1998-09-11
WO1998038993A1 (en) 1998-09-11
JP2001507363A (ja) 2001-06-05
RU2179440C2 (ru) 2002-02-20
EP0986383A1 (en) 2000-03-22
BR9808157A (pt) 2000-03-28
AU6335198A (en) 1998-09-22
PL335506A1 (en) 2000-04-25
IL131628A0 (en) 2001-01-28
KR20000075919A (ko) 2000-12-26
US6441029B1 (en) 2002-08-27
NO994309L (no) 1999-09-03
HUP0002049A2 (hu) 2000-10-28

Similar Documents

Publication Publication Date Title
NO994309D0 (no) FremgangsmÕter for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner
NO975759D0 (no) Inokuleringsmiddel og fremgangsmåte for fremstilling av inokuleringsmiddel
EP1037641A4 (en) LURE OF THE TRANSCRIPTION FACTOR AND INHIBITOR OF TUMOR GROWTH
NO20021382L (no) Fremgangsmåter og mikroorganismer for fremstilling av panto- forbindelser
NO20012978L (no) Fremgangsmåte og preparater for behandling av alvorlig bronkitt med et aerosolisert antibiotikum
HU9700602D0 (en) New inhibitors of bone-resorption and vitronectine-receptor-antagonists
NO971015D0 (no) Forbindelser og metoder for behandling av cancer
ATE197122T1 (de) Hämorrhoidenzusammensetzungen und verfahren zur verwendung
DK370486A (da) Hmg-coa-reduktaseinhibitor og fremgangsmaade til fremstilling deraf
EP1097165A4 (en) NEW INHIBITORS OF ANGIOGENESIS AND TUMOR GROWTH
NO20014680D0 (no) Festeanordning for ledd/navsammenstilling og fremgangsmåte for anvendelse
DE69411987D1 (de) Lautsprecheraufbau und Methode zur Assemblierung
NO20001554L (no) FremgangsmÕter og mellomprodukter nyttige for Õ fremstille antifolater
FI980246A (fi) Menetelmä keittimen käyttämiseksi ja keitin
DK277388D0 (da) Phosphorholdige hmg-coa-reduktase-inhibitorer, mellemprodukter og fremgangsmaade
EP0970612A4 (en) INHIBITORS OF ALGAE GROWTH AND MICROBIAL PROPAGATION AND THEIR USE
NO20005680D0 (no) Kombinasjoner av protein-farnesyltransferase og HMG CoA reduktase inhibitorer og anvendelse derav for behandling av cancer
DK485888D0 (da) Hmg-coa reduktaseinhibitor og fremgangsmaade til fremstilling deraf
EP0947581A4 (en) CULTURAL MEDIUM AND ITS USE.
FI942528A (fi) Kenkä ja menetelmä kengän kiinnittämiseksi
DE69900802T2 (de) MnMgCuZn-Ferrit und dessen Verwendung
DE69707827T2 (de) Aufzeichnungsanzeigemedium und dessen Verwendung
NO990018D0 (no) Belegg og fremgangsmÕte for fremstilling derav
DK486088A (da) Hmg-coa reduktaseinhibitor og fremgangsmaade til fremstilling deraf
NO971994D0 (no) Vekstmedium of fremgangsmåte

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application